Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SYRS Gross Margin

The Gross Margin of Syros Pharmaceuticals Inc (SYRS) is 7775.20%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

SYRS Gross Margin - Historical Value
Date Value
2023-12-31 7775.20%
SYRS Gross Margin - Peers Comparison